Health
Study confirms rare blood clotting risk linked to ChAdOx1-S vaccine – benefits still outweigh risks – News-Medical.Net
New research published in BMJ confirmed evidence of blood clotting finding a small risk after receiving one Oxford-AstraZeneca ChAdOx1-S severe acute respiratory…
Pharmaceutical and biotechnology company AstraZeneca had recently come under fire for rare blood clotting events — causing a temporary suspension of the vaccine in multiple countries. In April, the European Medicines Agency concluded the vaccine is potentially linked to blood clotting in people with low blood platelets who received the dose. However, they emphasized unusual blood clotting was a rare side effect.
New research published in BMJ confirmed evidence of blood clotting finding a small risk…
-
Business14 hours agoWarning! These ASX 200 shares were just downgraded
-
Business12 hours ago2 monthly payers you’ll want to own in 2025 and beyond
-
General23 hours agoTelco Exetel fined $694K after scammers bypass verification processes, access bank accounts
-
General22 hours agoSergio Perez and Valtteri Bottas to return to Formula 1 with Cadillac